A61P 9/08
Vasodilators for multiple indications
A61P9/08 (Vasodilators for multiple indications) appears on 4,519 US grants and 4,127 published applications in this corpus.
Search patents in A61P- Granted patents
- 4,519
- Published applications
- 4,127
- Assignees
- 1,731
- Inventors
- 10,997
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 27 | 0 |
| 1978 | 31 | 0 |
| 1979 | 32 | 0 |
| 1980 | 28 | 0 |
| 1981 | 42 | 0 |
| 1982 | 40 | 0 |
| 1983 | 33 | 0 |
| 1984 | 34 | 0 |
| 1985 | 65 | 0 |
| 1986 | 72 | 0 |
| 1987 | 88 | 0 |
| 1988 | 86 | 0 |
| 1989 | 100 | 0 |
| 1990 | 93 | 0 |
| 1991 | 108 | 0 |
| 1992 | 84 | 0 |
| 1993 | 68 | 0 |
| 1994 | 73 | 0 |
| 1995 | 96 | 0 |
| 1996 | 105 | 0 |
| 1997 | 154 | 0 |
| 1998 | 184 | 0 |
| 1999 | 121 | 0 |
| 2000 | 98 | 0 |
| 2001 | 93 | 30 |
| 2002 | 115 | 160 |
| 2003 | 121 | 234 |
| 2004 | 85 | 282 |
| 2005 | 124 | 269 |
| 2006 | 120 | 276 |
| 2007 | 107 | 244 |
| 2008 | 112 | 258 |
| 2009 | 139 | 353 |
| 2010 | 188 | 334 |
| 2011 | 184 | 258 |
| 2012 | 212 | 222 |
| 2013 | 181 | 190 |
| 2014 | 164 | 172 |
| 2015 | 142 | 138 |
| 2016 | 113 | 121 |
| 2017 | 96 | 111 |
| 2018 | 85 | 82 |
| 2019 | 65 | 87 |
| 2020 | 49 | 68 |
| 2021 | 45 | 56 |
| 2022 | 33 | 54 |
| 2023 | 15 | 39 |
| 2024 | 27 | 44 |
| 2025 | 11 | 26 |
| 2026 | 13 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof18 Aug 2026US 12,708,604 B2Xi'an Hanfeng Pharmaceutical Co., Ltd.
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Crystal of compound X7 hydrochloride and its preparation method and application19 May 2026US 12,630,545 B2ORxes Therapeutics Co., Ltd.
- Therapeutic agent of peripheral blood flow disorder28 Apr 2026US 12,611,430 B2Kyoto Prefectural Public University Corporation
- Retinal vasodilator and pharmaceutical composition3 Sep 2026US 2026/0256731 A1Teikyo University
- Phenyl-substituted dihydronaphthyridine compounds, and preparation and use thereof27 Aug 2026US 2026/0250278 A1Jiangsu Suzhong Pharmaceutical Research Institute Co., Ltd.
- Fc region variant27 Aug 2026US 2026/0250360 A1Chugai Seiyaku Kabushiki Kaisha
- Method of treating raynaud's conditions or erectile dysfunction6 Aug 2026US 2026/0224653 A1Bioharvest Ltd.
- Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof30 Jul 2026US 2026/0216191 A1Topadur Pharma AG
Most cited
By later US patents
- Adjunct material for delivery to colon tissue490US 10,188,389 B2Ethicon, Inc. · 2019
- Human antibodies that bind human TNFα308US 6,258,562 B1BASF SE · 2001
- Water-soluble non-antigenic polymer linkable to biologically active material304US 6,113,906 AEnzon, Inc. · 2000
- Fatty acid composition290US 5,502,077 ANorsk Hydro A/S · 1996
- Water soluble paclitaxel prodrugs272US 5,977,163 APG-TXL Company, L. P. · 1999